CureVac NV (CVAC)
CureVac Market Cap : 1.049B for Feb. 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BioNTech SE | 27.69B |
| Immatics NV | 1.252B |
| Bayer AG | 54.11B |
| MediGene AG | 1.474M |
| InflaRx NV | 58.61M |
Market Cap Related Metrics
| PE Ratio | 6.521 |
| PS Ratio | 12.94 |
| PEG Ratio | 0.2068 |
| Price to Book Value | 1.025 |
| Price | 4.66 |
| Earnings Yield | 15.33% |
| PEGY Ratio | 0.2068 |
| Normalized PE Ratio | 6.479 |